Evaluation of an albumin-binding gadolinium contrast agent in multiple sclerosis

Conclusion:
Gadofosveset trisodium after 4 hours significantly improves the number of detected contrast-enhanced multiple sclerosis lesions as compared to Gd-DOTA after 4 minutes, even though the injected dose of gadolinium was two-thirds lower.

Source: Neurology - July 15, 2013 Category: Neurology Authors: Kremer, S., Lamy, J., Magnus, A., Oesterle, H., Jeantroux, J., Trunet, S., Armspach, J.-P., Dietemann, J.-L., de Seze, J. Tags: MRI, Clinical trials Observational study (Cohort, Case control), Multiple sclerosis ARTICLE Source Type: research